FDA Investigating Salmonella Outbreak Linked to Moringa Powder

Got story updates? Submit your updates here. ›

The U.S. Centers for Disease Control and Prevention, Food and Drug Administration, and state health officials are investigating a Salmonella outbreak potentially linked to certain lots of Rosabella-brand moringa powder capsules. At least 7 illnesses, including 3 hospitalizations, have been reported across 7 states. The product distributor has voluntarily recalled the affected lots, which were sold online and through various retailers.

Why it matters

Moringa powder is a popular supplement touted for its health benefits, but the claims around its efficacy are not well-supported by research. This outbreak highlights the potential risks of consuming certain supplements, especially those making unsubstantiated health claims. It also underscores the importance of thorough oversight and investigation by public health agencies to protect consumers.

The details

The FDA, CDC, and state health officials are investigating the Salmonella outbreak linked to Rosabella-brand moringa powder capsules. The affected lots, which have expiration dates from March 2027 to November 2027, were sold through the Rosabella website, TikTok shop, eBay, Shein, and other retailers. The distributor, Ambrosia Brands, has voluntarily recalled the potentially contaminated product. Consumers are urged to dispose of the recalled capsules, wash any surfaces that may have come into contact with them, and monitor for Salmonella symptoms like fever, dehydration, diarrhea, and vomiting.

• The investigation into the Salmonella outbreak linked to Rosabella moringa powder began in February 2026.

What’s next

The FDA and CDC will continue to investigate the Salmonella outbreak and provide updates to the public as more information becomes available.